Cargando…

Tumor board review : guideline and case reviews in oncology /

Praise for the First Edition: "As everyone in oncology fellowship training knows, there is a huge [information] gap in this field. Most oncology books are massive and loaded with information by the time the book is [published] it is outdated." [Tumor Board Review] is fresh and just out of...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Todd, Robert F., III (Editor ), Cooney, Kathleen A. (Editor ), Hayes, Teresa G. (Editor ), Mims, Martha Pritchett (Editor ), Worden, Francis P. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Demos Medical, [2015]
Edición:Second edition.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Ii 4500
001 EBSCO_ocn904138399
003 OCoLC
005 20231017213018.0
006 m o d
007 cr cnu---unuuu
008 150227s2015 nyu ob 001 0 eng d
010 |a  2014040453 
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d EBLCP  |d N$T  |d E7B  |d CUI  |d OCLCF  |d YDXCP  |d VLB  |d NLGGC  |d OCLCQ  |d K6U  |d LVT  |d OCLCO  |d COCUF  |d CCO  |d PIFFA  |d FVL  |d ZCU  |d OCLCO  |d AGLDB  |d OCLCO  |d MERUC  |d U3W  |d D6H  |d STF  |d OCLCQ  |d VTS  |d FQM  |d ICG  |d JSJ  |d OCLCO  |d VT2  |d OCLCO  |d AU@  |d OCLCO  |d OCLCQ  |d WYU  |d OCLCO  |d TKN  |d DKC  |d OCLCO  |d OCLCQ  |d OCLCO  |d UKAHL  |d UX1  |d OCLCO  |d OCLCQ  |d OCLCA  |d OCLCO  |d OCLCQ 
019 |a 1055401596  |a 1066581882  |a 1081233048  |a 1228562567 
020 |a 9781617052231  |q (electronic bk.) 
020 |a 161705223X  |q (electronic bk.) 
020 |z 9781620700600 
020 |z 1620700603 
029 1 |a AU@  |b 000062420397 
029 1 |a DEBBG  |b BV042794979 
029 1 |a DEBBG  |b BV044073562 
029 1 |a DEBSZ  |b 493159142 
029 1 |a AU@  |b 000066757546 
029 1 |a AU@  |b 000069303060 
035 |a (OCoLC)904138399  |z (OCoLC)1055401596  |z (OCoLC)1066581882  |z (OCoLC)1081233048  |z (OCoLC)1228562567 
050 4 |a RC254  |b .T86 2015eb 
060 1 0 |a QZ 200 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 4 |a 616.99/4  |2 23 
049 |a UAMI 
245 0 0 |a Tumor board review :  |b guideline and case reviews in oncology /  |c editors, Robert F. Todd III, Kathleen A. Cooney, Teresa G. Hayes, Martha Pritchett Mims, Francis P. Worden. 
250 |a Second edition. 
264 1 |a New York :  |b Demos Medical,  |c [2015] 
300 |a 1 online resource (xv, 431 pages). 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b html  |2 rda 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
520 |a Praise for the First Edition: "As everyone in oncology fellowship training knows, there is a huge [information] gap in this field. Most oncology books are massive and loaded with information by the time the book is [published] it is outdated." [Tumor Board Review] is fresh and just out of the oven I haven't seen any book in oncology like this so far I think my investment in this book was wise and worth it."--Humaid Al- Shamsi, MB(Hon), BMedSc, MRCP(UK), FRCP, FACP, Assistant Professor, The University of Texas, MD Anderson Cancer Center Culling the knowledge and expertise of respected oncology specialists, this is a concise yet comprehensive review of all areas of oncology practice for medical oncologists, radiation oncologists, and pathologists--both students and practitioners. The second edition of Tumor Board Review has been thoroughly revised to encompass recent scientific advances in assessment and treatment, new clinical guidelines, and new FDA-approved drugs and indications. It also contains approximately 350 multiple-choice questions and answers to assist readers in testing their knowledge, especially those preparing for the MOC exam. The book features case presentations and evidence-based management discussions that clearly demonstrate how to apply new information in daily practice. In a consistent format, each chapter addresses epidemiology, risk factors, natural history, and pathology of each major organ-specific tumor type; an abbreviated display of relevant staging; and several "tumor board style" illustrative patient case studies. This is followed by an evidence-based case discussion, which reinforces current guidelines and explains the rationale for the diagnostic and therapeutic steps taken. Algorithms and decision-tree graphics further illuminate the decision process. New to the Second Edition of Tumor Board Review: Revised and updated with state-of-the-art knowledge Presents the most recent guidelines and management. -- Rittenhouse. 
505 0 |a Cover; Title; Copyright; Contents; Contributors; Preface to the Second Edition; Preface to the First Edition; Share Tumor Board Review: Guideline and Case Reviews in Oncology, Second Edition; Chapter 1: Head and Neck Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Overview of Staging; Site-Specific Staging for SCCHN; Case Summaries; Locoregionally Advanced Disease; Evidence-Based Case Discussion; Recurrent/Metastatic SCCHN; Evidence-Based Case Discussion; Summary; Review Questions; References; Chapter 2: Thyroid Cancer. 
505 8 |a Epidemiology, Risk Factors, Natural History, and PathologyDifferentiated Thyroid Carcinoma; Staging; Case Summaries; Early-Stage Papillary Thyroid Cancer: Stage I; Evidence-Based Case Discussion; Differentiated Follicular Thyroid Cancer: Late-Stage Follicular Thyroid Cancer; Evidence-Based Case Discussion; Medullary Thyroid Cancer; Evidence-Based Case Discussion; Anaplastic Thyroid Cancer; Evidence-Based Case Discussion; Review Questions; References; Chapter 3: Non-Small-Cell Lung Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; Early-Stage NSCLC. 
505 8 |a Evidence-Based Case DiscussionSurgery and Adjuvant Chemotherapy in Early-Stage NSCLC; Regional (Stage III) NSCLC; Evidence-Based Case Discussion; Metastatic NSCLC, Case 1; Evidence-Based Case Discussion; Metastatic NSCLC, Case 2; Evidence-Based Case Discussion; Recurrent NSCLC; Evidence-Based Case Discussion; Review Questions; References; Chapter 4: Small Cell Lung Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; LS-SCLC: Combined Modality Therapy; Evidence-Based Case Discussion; ES-SCLC: Systemic Palliative Therapy; Evidence-Based Case Discussion. 
505 8 |a Review QuestionsReferences; Chapter 5: Breast Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; Ductal Carcinoma In Situ; Early-Stage ER+ Breast Cancer; Early-Stage ER+ Breast Cancer, Stage I or II; Early-Stage TNBC; Locally Advanced HER2+ Breast Cancer; Metastatic Breast Cancer; A Special Note on Breast Cancer in Pregnancy; Review Questions; References; Chapter 6: Esophageal Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; Locally Advanced Resectable Esophageal Cancer; Evidence-Based Case Discussion. 
505 8 |a Locally Advanced Unresectable Esophageal CancerEvidence-Based Case Discussion; Metastatic Esophageal Cancer; Evidence-Based Case Discussion; Acknowledgment; Review Questions; References; Chapter 7: Gastric Cancer; Epidemiology, Natural History, Risk Factors, and Pathology; Staging; Case Summaries; Resectable Gastric Cancer; Evidence-Based Case Discussion; Locally Advanced Unresectable and Metastatic Gastric Cancer; Evidence-Based Case Discussion; Review Questions; References; Chapter 8: Pancreatic Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Tumors  |v Case studies. 
650 0 |a Evidence-based medicine  |v Case studies. 
650 0 |a Evidence-based medicine. 
650 2 |a Evidence-Based Medicine 
650 2 |a Neoplasms 
650 2 |a Evidence-Based Practice 
650 6 |a Tumeurs  |v Études de cas. 
650 6 |a Médecine factuelle  |v Études de cas. 
650 6 |a Médecine factuelle. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Evidence-based medicine.  |2 fast  |0 (OCoLC)fst00917247 
650 7 |a Tumors.  |2 fast  |0 (OCoLC)fst01158759 
655 2 |a Case Reports 
655 2 |a Practice Guideline 
655 7 |a Case studies.  |2 fast  |0 (OCoLC)fst01423765 
700 1 |a Todd, Robert F.,  |c III,  |e editor. 
700 1 |a Cooney, Kathleen A.,  |e editor. 
700 1 |a Hayes, Teresa G.,  |e editor. 
700 1 |a Mims, Martha Pritchett,  |e editor. 
700 1 |a Worden, Francis P.,  |e editor. 
776 0 8 |i Print version:  |t Tumor board review.  |b Second edition  |z 9781620700600  |w (DLC) 2014040453  |w (OCoLC)893099401 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=959607  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH35067712 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL1969452 
938 |a ebrary  |b EBRY  |n ebr11026056 
938 |a EBSCOhost  |b EBSC  |n 959607 
938 |a YBP Library Services  |b YANK  |n 12316797 
994 |a 92  |b IZTAP